Difference between revisions of "Profiles"

Revision as of 15:26, 26 June 2017

Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.

Link to QIBA Public Comment Form: http://tinyurl.com/y8dy2pc2

QIBA fMRI Profile 2017-06-19 Public Comment to open on June 19, 2017
QIBA PET Amyloid Profile 2017-06-15 Public Comment is open until September 15, 2017
DWI Profile 2017-04-27 Public Comment is open until July 28, 2017

Stage 1: Public Comment closed

How to use QIBA Profiles
Biomarker Committee pages may also have links to DRAFT Profile documents for the next Stage.
Profile Conformance describes how sites and products claim conformance to a Profile.
QIBA Profile Template shows the structure, rationale and content of a Profile (show "All Markup" to see guidance in the Word comments)

@@ Line 6: / Line 6: @@
 ===[[QIBA_Profile_Stages#Stage_1:_Public_Comment|Stage 2]]: Consensus Profiles===
-*[[Media:001.QIBA_SPECT_Ioflupane Profile.v1.0 post-public comments.clean copy.2017 06 26.pdf | Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), June 26, 2017]]
+*[[Media:001.QIBA_SPECT_Ioflupane Profile.v1.1 post-public comments.clean copy.2017 06 26.pdf | Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), June 26, 2017]]
 :*[[Media:002.QIBA SPECT Profile Checklist Extract.2016 10 31.docx|Checklist: SPECT Profile Conformance]]
 * [[Media:QIBA_CTVol_TumorVolumeChangeProfile_Consensus-20161121b.pdf| CT Tumor Volumetry for Advanced Disease 2016-11-21b]]